It has been reported that in the excised cross-circulated dog heart model, cardiac cooling increases Emax (contractility index) and the external work (EW) of the left ventricle without affecting the systolic pressure volume area (PVA)-independent myocardial oxygen consumption (VO ). However, it remains unclear whether this cooling inotropism and oxygen-saving effect can also be demonstrated in an 2 in situ heart. In the present study, we investigated the effect of cardiac cooling under surface-induced hypothermia in the in situ heart to assess the practical application of this method. Adult mongrel dogs were examined under surface-induced hypothermia with or without vasodilator. Using conductance catheter, pressure-volume relationship were obtained and mechanoenergetical parameters were measured. Optimal temperature for cardiac cooling was also examined. Simple hypothermia increased Emax compared with normothermia without affecting PVA-independent VO , but EW did not increase. However, with concurrent vasodilator administration, cardiac cooling increased 2 not only Emax but also EW without affecting PVA-independent VO compared with normothermia. However, at temperature below 32 8C, 2 Tau increased significantly and diastolic dysfunction was noted. Cardiac cooling with concurrent vasodilator administration in the in situ heart has inotropic and oxygen-saving effects and optimal temperature for cardiac cooling is thought to be 34 8C.
Introduction
Induced hypothermia has been used clinically to lower whole-body and myocardial oxygen demand after cardiac surgery w1x. Moreover, it has been reported that cardiac cooling increases its contractility w2x.
From mechanoenergetical approach, Suga et al. found that cardiac cooling increased contractility index (Emax) without affecting relation between O consumption per 2 beat (VO ) and systolic pressure-volume area (PVA) and 2 they proved that cooling inotropism has an oxygen-saving effect compared to catecholamines in the excised crosscirculated dog heart preparation w3x. If this oxygen-saving effect of cooling inotropism can be applied for the in situ heart, it could contribute to postoperative management for failing heart in cardiac surgery.
Unlike the excised cross-circulated heart preparation, the change in preload and afterload directly affects cardiac pump function in the in situ heart. Therefore, it is not clear whether the cooling inotropic effect in the excised heart preparation can also be demonstrated in the in situ heart. *Corresponding author: Department of Thoracic and Cardiovascular Surgery, Wakayama Medical University, Kimiidera 811-1, Wakayama city, Wakayama, Japan. Tel.: q81-073-447-2300; fax: q81-073-446-4761.
E-mail address: nishim-y@wakayama-med.ac.jp (Y. Nishimura).
This study assessed the effect of cardiac cooling in the in situ heart under surface-induced hypothermia using pressure-volume relationship as well as the optimal temperature for cardiac cooling in the in situ heart to evaluate the clinical application of this method.
Subjects and methods

Experimental settings
The experiment was conducted on adult mongrel dogs. All of the animals involved in this experiment were treated according to guidelines recommended by the Japanese Association of Experimental Animals. Under anesthesia with intramuscular administration of 7 mgykg of Ketamine hydrochloride and continuous intravenous administration of 0.08 mgykgymin of pentobarbital sodium, the animals were placed under artificial ventilation Then, 0.7 mgykgymin of atropine sulfate and 3 mgykgymin propranolol hydrochloride were administered continuously throughout the experiment to block the autonomic reflex and the effect of endogenous catecholamines w4x. Following left thoracotomy, a pulse Doppler blood flowmeter (VF-1, Crystal Biotec Inc.) was applied proximal to the circumflex branch of the left coronary artery. A micro-manometer (8 Fr, Sentron Inc.) and a conductance catheter (7 Fr, LEYCOM Inc.) were inserted from the cardiac apex into the left ventricle to PVAs EW q PE (Fig. 1 A) . Emax is the slope of end systolic pressure volume relation during transient caval occlusion (Fig. 1B) . pendent VO , which was consisted of calcium ion handling for excitation con-2 traction coupling and basal metabolism ( Fig. 2A) . The axis intercept of linear regression line of VO -PVA relation determines PVA-independent VO (Fig. 2B) .
2 2 continuously measure the left ventricular pressure and left ventricular volume, while simultaneously examining the left ventricular pressure-volume relationship. The conductances were summed and converted to volume using the computer system Sigma 5 (LEYCOM Inc.) w5x.
The dogs were gradually cooled in the bath-tub filled by water and ice bag especially constructed for this purpose. Blood temperature was continuously monitored and the ice bags were placed in such a manner that a given degree of cooling temperature was maintained for about 30 min as a steady condition.
Measurement parameters
Systolic elastance (Emax; mmHgyml)
The Emax has been reported to be obtained as the slope of the systolic pressure-volume relation (straight line) and to be an index of the left ventricular contractility that does not depend on the loading conditions of the heart w6,7x. A pressure-volume curve was drawn by changing the preload via transient occlusion of the inferior vena cava, and Emax was calculated as the slope of a regression line obtained from the endsystolic pressure-volume points (Fig.  1A, B ).
External work (EW; mmHgØml)
EW, represented by the area surrounded by the pressurevolume loop, is the work of the left ventricle per beat to eject blood against the aortic pressure.
Stroke volume (SV; ml)
SV is represented as the length of the volume axis of the pressure-volume-area loop.
Pressure-volume area (PVA; mmHgØml)
PVA is the area in the pressure-volume diagram that is circumscribed by end-systolic and end-diastolic pressurevolume relation curves and the systolic segment of the pressure-volume loop trajectory. It consists of EW and potential energy (PE), and shows the total mechanical energy produced by one heart beat w8x (Fig. 1A) .
Myocardial oxygen consumption volume (VO
min) The left circumflex area VO (CxVO ) was used as an index 2 2 of VO . The CxVO was calculated from the product of the 2 2 blood volume in the circumflex branch of the left coronary artery (VO ; ml O ymin) and the coronary arteriovenous 2 2 oxygen difference (Vol%) (CxVO per min) divided by 100.
2
The blood flow in the circumflex branch of the left coronary artery was measured with a pulse Doppler flow meter.
VO -PVA relationship per beat 2
The relationship between VO and PVA per beat obtained 2 by alternately changing the preload and afterload is represented as a straight line, shown in Fig. 2A and Fig. 2B . The VO axis intercept represents the oxygen consumption 2 required for the myocardial basal metabolism and calcium handling in excitation contraction coupling, i.e., PVA independent VO . 
Cardiac output (CO; lymin)
CO was obtained from the product of heart rate (HR) by SV.
Systemic vascular resistance (SVR;NØsecØm
SVR was calculated using standard formula w9x.
Experiment protocol
Experiment 1 (simple hypothermia)
Five adult mongrel dogs weighing 12.3"1.6 kg were used in this experiment. At first, mBP, CVP, HR, left ventricular pressure, volume, coronary blood flow, and coronary arteriovenous oxygen difference were measured under steadystate hemodynamic condition under normothermia (37-38 8C), and Emax, EW, PVA, CxVO , VO -PVA relation, CO, 2 2 and SVR were calculated under normothermia. Surface hypothermia was then induced in the same adult dogs under the same conditions to decrease the blood temperature to 32 8C. After stabilizing the hemodynamics, the same measurements as those obtained under normothermia were then obtained under hypothermic conditions (hypothermia). 
Experiment 2 (hypothermia using vasodilator)
Five adult mongrel dogs weighing 15.4"3.2 kg were used in this experiment. To examine the effect of the vasodilator, each parameter drscribed above was measured under normothermia (37-38 8C). Following intravenous administration of 15 mgykgymin of the ganglion blocking agent trimethaphan camsylate (Arfonad , Nippon Roche) as a ᭨ vasodilator, each parameter was measured again (normothermia with trimethaphan). Then, the blood temperature was lowered to 32 8C by surface hypothermia under administration of trimethaphan (hypothermia with trimethaphan).
Experiment 3 (optimal temperature for cardiac cooling in the in situ heart)
Five adult mongrel dogs weighing 15.6"3.0 kg were used in this experiment. As the vasodilator, Chlorpromazine hydrochloride (CPZ; Contomine , Yoshitomi) was used In ᭨ this experiment, m BP, HR, Emax, EW, Work efficiency (WE; defined as EWyPVA), CO was measured. To access the parameter of diastolic function, the time constant (Tau) of isovolumic left ventricular pressure decline was also calculated. Following intravenous administration of 5 mgykgy min of CPZ, each parameter was measured (normothermia with CPZ). The blood temperature was lowered to 34 8C by surface hypothermia under administration of CPZ (34 8C with CPZ) and each parameter was measured. Then, the temperature was lowered to 32 8C(32 8C with CPZ) and each parameter was measured.
The measured values are expressed as mean"S.D. and the measured values under the respective conditions were compared using paired t-test and one way analysis of variance (ANOVA) with a significance level of P-0.05.
Results
Experiment 1 (simple hypothermia)
Experimental data from five animals are shown in Table  1 . Emax significantly increased under hypothermia (P-0.01). However, EW did not show any significant difference under normothermia and hypothermia. CO decreased significantly under hypothermia, as HR reduced (P-0.05). SVR showed a significant increase under hypothermia (P-0.05). VO axis intercept showed nearly equivalent 2 values under normothermia and hypothermia.
Experiment 2 (hypothermia using vasodilator)
Experimental data from five animals are shown in Table  2 . Emax did not change with or without the use of trimethaphan under normothermia, while Emax increased significantly under hypothermia with trimethaphan (P-0.05). Like Emax, EW did not exhibit any significant difference with or without the use of trimethaphan under normothermia, and compared with those values, EW increased significantly under hypothermia with trimethaphan Table 3 Hemodynamic indices in the experiment 3 (optimal temperature for cardiac cooling in the in situ heart) NormqCPZ: Normothermic run using Chlorpromazine, 34 8CqCPZ: 34 8C using Chlorpromazine, 32 8CqCPZ: 32 8C using Chlorpromazine.
*: P-0.05 vs. NormoqCPZ, ࠻: P-0.05 vs. 34 8CqCPZ.
(P-0.05). CO was nearly equivalent in the three groups with no reduction even under hypothermia. When the VO -2 PVA relation under normothermia was compared with that under hypothermia with trimethaphan, the VO axis inter-2 cept under normothermia and hypothermia with trimethaphan showed almost equivalent values.
Experiment 3 (optimal temperature for cardiac cooling in the in situ heart)
Experimental data from five animals are shown in Table  3 . Emax increased significantly under 34 8C with CPZ, as compared with Emax under normothermia with CPZ (P-0.05); and Emax further increased significantly under 32 8C with CPZ, compared with Emax under the two conditions described above (P-0.05). EW significantly increased under hypothermia (P-0.05), but did not differ under 34 8C and 32 8C. WE (Work efficiency) increased significantly under 34 8C with CPZ, compared with WE under normothermia with CPZ (P-0.05), but did not differ under 34 8C and 32 8C. Tau did not significantly differ between normothermia with CPZ and 34 8C with CPZ, but Tau significantly increased under 32 8C with CPZ compared to that under 34 8C with CPZ (P-0.05).
Discussion
The mechanism of cooling inotropism as described in the previous reports include a decreased reaction rate of contractile protein and calcium ion, prolonged duration of excitation and contraction time, and slowing of cross bridge cycling w10-13x. Suga et al. reported that cardiac cooling increased Emax without affecting PVA-independent VO and 2 has energetically more advantages in saving myocardial oxygen consumption compared to catecholamine in crosscirculated dog heart preparations w3x.
The new findings in the present study are that in the in situ heart, cardiac cooling under surface-induced hypothermia with concurrent vasodilator administration has an inotropic effect and an oxygen-saving effect. The difference in the experimental model between the excised heart as described by Suga et al and the in situ heart examined in this study was the presence of peripheral vascular resistance. In the simple hypothermia experiment, cardiac contractility (Emax) increased, however, the external work of the left ventricle did not change. We hypothesized that the increased peripheral vascular resistance had an harmful effect on left ventricular afterload. Then, in the second experiment of this study, we use Trimethaphan Camsylate as a vasodilator. Consequently, with concurrent vasodilator administration, cardiac cooling increased Emax and external work, and did not change the VO axis intercept which 2 was equivalent to the basal metabolism and calcium handling in the excitation-contraction coupling. However, cardiac output did not increase, probably due to the decreased heart rate caused by hypothermia. We verified that Chlorpromazine hydrochloride had the same vasodilator effect as Trimethaphan Camsylate during cardiac cooling in the in situ heart. This result suggests that other vasodilators could be used in the same situation. Chlorpromazine hydrochloride is often used as a vasodilator during cardiopulmonary bypass in the cardiac surgery. We used Chlorpromazine hydrochloride to examine the practical application of this method.
Furthermore, we investigated the optimal temperature of cardiac cooling in the in situ heart. It is well known that one of the harmful effects of cardiac cooling is to induce ventricular fibrillation. Thinking of this harmful effect, we set up the temperature as normothermia, 34 8C and 32 8C in the experiment 3. We found that 34 8C was the optimal temperature for cardiac cooling in the in situ heart for the following reason. Although Emax increased the most under 32 8C, External work did not differ between 34 and 32 8C. Furthermore, Tau which is an index of ventricular relaxation or diastolic function significantly increased under 32 8C. These results suggest that under 32 8C reinforcement of systolic function was demonstrated. However, diastolic dysfunction was also demonstrated. Though the mechanism of diastolic dysfunction by cardiac cooling is not clearly understood, this side effect should be noted in therapeutic hypothermia.
The importance of peripheral vascular factor should be discussed not only hemodynamically but also metabolically, because, it would affect the cardiac function. In the present experiments metabolic abnormalities during hypothermia such as acidosis and electrolyte imbalance were corrected. However, in the clinical setting, rewarming process would produce the increased metabolic oxygen demand of the peripheral organs to the failing heart. Further evaluation will be necessary in the mechano-energetics of the rewarming heart.
